Vascular oxidative stress in Alzheimer disease

Journal of the Neurological Sciences

Volumn 257, Issue 1-2, 2007, Pages 240-246

  Zhu, Xiongwei ^a   Smith, Mark A ^a   Honda, Kazuhiro ^b   Aliev, Gjumrakch ^a   Moreira, Paula I ^c   Nunomura, Akihiko ^d   Casadesus, Gemma ^a   Harris, Peggy L R ^a   Siedlak, Sandra L ^a   Perry, George ^a,e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Shinmatsudo Central General Hospital   (Japan)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e University of San Antonio   (United States)

Author keywords

Alzheimer disease; Hypoperfusion; Mitochondria; Nitric oxide; Nitric oxide synthase; Oxidative stress; Vascular abnormalities

Indexed keywords

NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASODILATOR AGENT;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN PERFUSION; CONCENTRATION RESPONSE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

ALZHEIMER DISEASE; BRAIN; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; DEMENTIA, VASCULAR; ENDOTHELIAL CELLS; HUMANS; MITOCHONDRIA; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 34249776958     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.039     Document Type: Article

References (101)

1. Bostrom K., and Hassler O. A pilot microradiological investigation on the occurrence of calcifications in various arteries of the human body. J Gerontol 21 (1966) 97-102
2. Bell M.A., and Ball M.J. Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities. Acta Neuropathol (Berl) 53 (1981) 299-318
3. Mancardi G.L., Perdelli F., Rivano C., Leonardi A., and Bugiani O. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol (Berl) 49 (1980) 79-83
4. Donahue J.E., Berzin T.M., Rafii M.S., Glass D.J., Yancopoulos G.D., Fallon J.R., and Stopa E.G. Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc Natl Acad Sci U S A 96 (1999) 6468-6472
5. Perry G., Smith M.A., McCann C.E., Siedlak S.L., Jones P.K., and Friedland R.P. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res 791 (1998) 63-66
6. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5 (2004) 347-360
7. Crawford J.G. Alzheimer's disease risk factors as related to cerebral blood flow: additional evidence. Med Hypotheses 50 (1998) 25-36
8. Stewart P.A., Hayakawa K., Akers M.A., and Vinters H.V. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 67 (1992) 734-742
9. Hachinski V., and Munoz D.G. Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?. Ann NY Acad Sci 826 (1997) 1-6
10. Kalaria R.N. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann NY Acad Sci 893 (1999) 113-125
11. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21 (2000) 321-330
12. Kawai M., Kalaria R.N., Harik S.I., and Perry G. The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 137 (1990) 1435-1446
13. Tagliavini F., Ghiso J., Timmers W.F., Giaccone G., Bugiani O., and Frangione B. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab Invest 62 (1990) 761-767
14. Suo Z., Su G., Placzek A., Kundtz A., Humphrey J., Crawford F., and Mullan M. A beta vasoactivity in vivo. Ann NY Acad Sci 903 (2000) 156-163
15. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78 (1998) 53-97
16. Lum H., and Roebuck K.A. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280 (2001) C719-C741
17. Zhu X., Lee H.G., Casadesus G., Avila J., Drew K., Perry G., and Smith M.A. Oxidative imbalance in Alzheimer's disease. Mol Neurobiol 31 (2005) 205-217
18. Zhu X., Raina A.K., Lee H.G., Casadesus G., Smith M.A., and Perry G. Oxidative stress signalling in Alzheimer's disease. Brain Res 1000 (2004) 32-39
19. Lovell M.A., Xie C., and Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51 (1998) 1562-1566
20. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., and Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23 (1998) 81-88
21. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., et al. Oxidative damage in Alzheimer's. Nature 382 (1996) 120-121
22. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., and Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68 (1997) 2092-2097
23. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Praprotnik D., Mulvihill P., Miller C.A., et al. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 64 (1995) 2660-2666
24. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., and Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17 (1997) 2653-2657
25. Mecocci P., MacGarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.C., et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 34 (1993) 609-616
26. Mecocci P., MacGarvey U., and Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36 (1994) 747-751
27. Mecocci P., Beal M.F., Cecchetti R., Polidori M.C., Cherubini A., Chionne F., et al. Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol Chem Neuropathol 31 (1997) 53-64
28. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19 (1999) 1959-1964
29. Nunomura A., Chiba S., Lippa C.F., Cras P., Kalaria R.N., Takeda A., et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 17 (2004) 108-113
30. Nunomura A., Perry G., Pappolla M.A., Friedland R.P., Hirai K., Chiba S., et al. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59 (2000) 1011-1017
31. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 (2001) 759-767
32. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.D., Stern D., et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A 91 (1994) 5710-5714
33. Smith M.A., Richey P.L., Taneda S., Kutty R.K., Sayre L.M., Monnier V.M., et al. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann NY Acad Sci 738 (1994) 447-454
34. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19 (1998) 33-36
35. Markesbery W.R., and Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol 9 (1999) 133-146
36. Rottkamp C.A., Nunomura A., Raina A.K., Sayre L.M., Perry G., and Smith M.A. Oxidative stress, antioxidants, and Alzheimer disease. Alzheimer Dis Assoc Disord 14 Suppl 1 (2000) S62-S66
37. Rinaldi P., Polidori M.C., Metastasio A., Mariani E., Mattioli P., Cherubini A., et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24 (2003) 915-919
38. Riviere S., Birlouez-Aragon I., Nourhashemi F., and Vellas B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 13 (1998) 749-754
39. Bourdel-Marchasson I., Delmas-Beauvieux M.C., Peuchant E., Richard-Harston S., Decamps A., Reignier B., et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30 (2001) 235-241
40. Riviere S., Birlouez-Aragon I., and Vellas B. Plasma protein glycation in Alzheimer's disease. Glycoconj J 15 (1998) 1039-1042
41. Pratico D. Alzheimer's disease and oxygen radicals: new insights. Biochem Pharmacol 63 (2002) 563-567
42. Perry G., Castellani R.J., Smith M.A., Harris P.L., Kubat Z., Ghanbari K., et al. Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol (Berl) 106 (2003) 552-556
43. Mecocci P., Polidori M.C., Ingegni T., Cherubini A., Chionne F., Cecchetti R., and Senin U. Oxidative damage to DNA in lymphocytes from AD patients. Neurology 51 (1998) 1014-1017
44. Mecocci P., Polidori M.C., Cherubini A., Ingegni T., Mattioli P., Catani M., et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 59 (2002) 794-798
45. Aliev G., Seyidova D., Neal M.L., Shi J., Lamb B.T., Siedlak S.L., et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 977 (2002) 45-64
46. Aliyev A., Chen S.G., Seyidova D., Smith M.A., Perry G., de la Torre J., et al. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci 229-230 (2005) 285-292
47. Aliev G., Cirillo R., Salvatico E., Paro M., and Prosdocimi M. Changes in vessel ultrastructure during ischemia and reperfusion of rabbit hindlimb: implications for therapeutic intervention. Microvasc Res 46 (1993) 65-76
48. Salvatico E., Aliev G.M., Novello D., and Prosdocimi M. Functional depression of isolated perfused rat heart mediated by activated leukocytes: protective effect of cloricromene. J Cardiovasc Pharmacol 24 (1994) 638-647
49. Al-Abdulla N.A., and Martin L.J. Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am J Pathol 153 (1998) 447-456
50. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21 (2001) 3017-3023
51. Maxwell A.J. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 6 (2002) 101-124
52. Naseem K.M. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26 (2005) 33-65
53. Garthwaite J., and Beaumont P.S. Excitatory amino acid receptors in the parallel fibre pathway in rat cerebellar slices. Neurosci Lett 107 (1989) 151-156
54. Iadecola C., Li J., Ebner T.J., and Xu X. Nitric oxide contributes to functional hyperemia in cerebellar cortex. Am J Physiol 268 (1995) R1153-R1162
55. Iadecola C., Zhang F., Xu S., Casey R., and Ross M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 15 (1995) 378-384
56. Iadecola C., Zhang F., Casey R., Clark H.B., and Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 27 (1996) 1373-1380
57. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63 (1994) 175-195
58. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271 (1996) C1424-C1437
59. Luth H.J., Holzer M., Gartner U., Staufenbiel M., and Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res 913 (2001) 57-67
60. Luth H.J., Munch G., and Arendt T. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 953 (2002) 135-143
61. Williamson K.S., Gabbita S.P., Mou S., West M., Pye Q.N., Markesbery W.R., et al. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6 (2002) 221-227
62. Bogumil R., Knipp M., Fundel S.M., and Vasak M. Characterization of dimethylargininase from bovine brain: evidence for a zinc binding site. Biochemistry 37 (1998) 4791-4798
63. Kimoto M., Whitley G.S., Tsuji H., and Ogawa T. Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo) 117 (1995) 237-238
64. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russell R.J., Hodson H., et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119 (1996) 1533-1540
65. Smith M.A., Vasak M., Knipp M., Castellani R.J., and Perry G. Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease. Free Radic Biol Med 25 (1998) 898-902
66. Selley M.L. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol Aging 24 (2003) 903-907
67. Abe T., Tohgi H., Murata T., Isobe C., and Sato C. Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 312 (2001) 177-179
68. Haas J., Storch-Hagenlocher B., Biessmann A., and Wildemann B. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett 322 (2002) 121-125
69. Heneka M.T., Wiesinger H., Dumitrescu-Ozimek L., Riederer P., Feinstein D.L., and Klockgether T. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol 60 (2001) 906-916
70. Barford P.A., Blair J.A., Eggar C., Hamon C., Morar C., and Whitburn S.B. Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry 47 (1984) 736-738
71. Aziz A.A., Leeming R.J., and Blair J.A. Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry 46 (1983) 410-413
72. Stroes E., Hijmering M., van Zandvoort M., Wever R., Rabelink T.J., and van Faassen E.E. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett 438 (1998) 161-164
73. Luth H.J., Holzer M., Gertz H.J., and Arendt T. Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. Brain Res 852 (2000) 45-55
74. Salvemini D., and Marino M.H. Inducible nitric oxide synthase and inflammation. Expert Opin Investig Drugs 7 (1998) 65-75
75. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30 (1990) 535-560
76. Wong A., Luth H.J., Deuther-Conrad W., Dukic-Stefanovic S., Gasic-Milenkovic J., Arendt T., et al. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res 920 (2001) 32-40
77. Fernandez-Vizarra P., Fernandez A.P., Castro-Blanco S., Encinas J.M., Serrano J., Bentura M.L., et al. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol Dis 15 (2004) 287-305
78. Lee S.C., Zhao M.L., Hirano A., and Dickson D.W. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. J Neuropathol Exp Neurol 58 (1999) 1163-1169
79. Nathan C., Calingasan N., Nezezon J., Ding A., Lucia M.S., La Perle K., et al. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med 202 (2005) 1163-1169
80. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33 (2002) 1152-1162
81. Colton C.A., Brown C.M., Cook D., Needham L.K., Xu Q., Czapiga M., et al. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging 23 (2002) 777-785
82. Brown C.M., Wright E., Colton C.A., Sullivan P.M., Laskowitz D.T., and Vitek M.P. Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med 32 (2002) 1071-1075
83. Colton C.A., Needham L.K., Brown C., Cook D., Rasheed K., Burke J.R., et al. APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol 147 (2004) 62-67
84. Chibber R., Molinatti P.A., Rosatto N., Lambourne B., and Kohner E.M. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 40 (1997) 156-164
85. Graier W.F., Posch K., Wascher T.C., and Kostner G.M. Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia. Horm Metab Res 29 (1997) 622-626
86. Pieper G.M., Jordan M., Dondlinger L.A., Adams M.B., and Roza A.M. Peroxidative stress in diabetic blood vessels. Reversal by pancreatic islet transplantation. Diabetes 44 (1995) 884-8849
87. Lang D., Kredan M.B., Moat S.J., Hussain S.A., Powell C.A., Bellamy M.F., et al. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler Thromb Vasc Biol 20 (2000) 422-427
88. Shimohama S., Tanino H., Kawakami N., Okamura N., Kodama H., Yamaguchi T., et al. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 273 (2000) 5-9
89. Perry G., and Epel D. Fertilization stimulates lipid peroxidation in the sea urchin egg. Dev Biol 107 (1985) 58-65
90. Perry G., and Epel D. Characterization of a Ca2+-stimulated lipid peroxidizing system in the sea urchin egg. Dev Biol 107 (1985) 47-57
91. Zhu X., Smith M.A., Perry G., and Aliev G. Mitochondrial failures in Alzheimer's disease. Am J Alzheimer's Dis Other Dement 19 (2004) 345-352
92. Rodriguez G., Vitali P., Canfora M., Calvini P., Girtler N., De Leo C., et al. Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease. Clin Neurophysiol 115 (2004) 39-49
93. Rodriguez G., Vitali P., Calvini P., Bordoni C., Girtler N., Taddei G., et al. Hippocampal perfusion in mild Alzheimer's disease. Psychiatry Res 100 (2000) 65-74
94. Okamura N., Shinkawa M., Arai H., Matsui T., Nakajo K., Maruyama M., et al. Prediction of progression in patients with mild cognitive impairment using IMP-SPECT. Nippon Ronen Igakkai Zasshi 37 (2000) 974-978
95. Kogure D., Matsuda H., Ohnishi T., Asada T., Uno M., Kunihiro T., et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 41 (2000) 1155-1162
96. Johnson K.A., Jones K., Holman B.L., Becker J.A., Spiers P.A., Satlin A., et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50 (1998) 1563-1571
97. Johnson K.A., and Albert M.S. Perfusion abnormalities in prodromal AD. Neurobiol Aging 21 (2000) 289-292
98. Niwa K., Kazama K., Younkin L., Younkin S.G., Carlson G.A., and Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283 (2002) H315-H323
99. de la Torre J.C. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging 21 (2000) 331-342
100. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 79 (1999) 1431-1568
101. Sekhon L.H., Morgan M.K., Spence I., and Weber N.C. Chronic cerebral hypoperfusion: pathological and behavioral consequences. Neurosurgery 40 (1997) 548-556